This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biotech

Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial

Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial

Will the failure of Celladon's Mydicar gene therapy bring other high-flying gene therapy stocks down to Earth?

04/26/15 - 08:45 PM EDT

Apple Earnings, FOMC: What to Watch on Wall Street for the Week Ahead

For the week of April 27, Wall Street awaits earnings from Apple (AAPL), Twitter (TWTR), Ford (F), CVS Health (CVS), United Parcel Service (UPS), MasterCard (MA), Visa (V) and more.

04/26/15 - 12:00 PM EDT

Perrigo (PRGO) Stock Declines Today After Rejecting Second Mylan Bid This Week

Perrigo (PRGO) Stock Declines Today After Rejecting Second Mylan Bid This Week

  • Tickers in this article:
  • PRGO

Perrigo (PRGO) shares are falling after the company rejected Mylan's $33 billion offer for the company, the second time this week it has rejected a Mylan acquisition bid.

04/24/15 - 03:41 PM EDT

Catalyst Pharma Competitor Surprises With Positive Orphan Disease Drug Study Results

Catalyst Pharma Competitor Surprises With Positive Orphan Disease Drug Study Results

Catalyst and Jacobus Pharma are racing to secure FDA approval for a drug to treat a rare muscle-wasting disease.

04/24/15 - 12:05 PM EDT

Amazon Leads Stock Markets; Nasdaq Extends Record Run

Amazon Leads Stock Markets; Nasdaq Extends Record Run

The Nasdaq was the clear winner on markets Friday. The tech-heavy index spiked into record territory as Amazon (AMZN), Microsoft (MSFT) and Google (GOOGL) rallied after reporting earnings.

04/24/15 - 11:54 AM EDT

Jim Cramer Loves Regeneron, Sees Shares Headed to $500

Jim Cramer Loves Regeneron, Sees Shares Headed to $500

TheStreet's Jim Cramer remains bullish on several biotech stocks.

04/24/15 - 11:47 AM EDT

Mylan (MYL) Stock Gains Today After Increasing Second Perrigo Bid to $33 Billion

Mylan (MYL) Stock Gains Today After Increasing Second Perrigo Bid to $33 Billion

  • Tickers in this article:
  • MYL

Mylan (MYL) shares are climbing after the company announced a $33 billion bid for rival Perrigo (PRGO), the second offer for the company it made this week.

04/24/15 - 10:37 AM EDT

Biogen (BIIB) Stock Falls Today on Weak First Quarter Earnings Results

Biogen (BIIB) Stock Falls Today on Weak First Quarter Earnings Results

  • Tickers in this article:
  • BIIB

Biogen (BIIB) shares are declining following the release of the company's first quarter earnings results today.

04/24/15 - 09:42 AM EDT

Biogen, American Airlines: What to Watch on Wall Street April 24

Biogen, American Airlines: What to Watch on Wall Street April 24

For Friday, April 24 we watch for quarterly financial results from drug maker Biogen (BIIB), copy machine company Xerox (XRX), and American Airlines (AAL).

04/23/15 - 08:00 PM EDT

Alexion Pharmaceuticals (ALXN) Stock Fell Today on Missed Earnings, Weak Guidance

Alexion Pharmaceuticals (ALXN) Stock Fell Today on Missed Earnings, Weak Guidance

  • Tickers in this article:
  • ALXN

Alexion Pharmaceuticals (ALXN) shares dropped after the company reported mixed first quarter financial results and provided weak full year guidance today.

04/23/15 - 04:15 PM EDT

Eli Lilly (LLY) Stock Rises Today Following Earnings Beat

Eli Lilly (LLY) Stock Rises Today Following Earnings Beat

  • Tickers in this article:
  • LLY

Eli Lilly (LLY) shares are climbing after the company beat analysts first quarter earnings and revenue expectations.

04/23/15 - 01:45 PM EDT

Teva Won't Let Regulators, Poison Pill Stop Its Quest for Mylan

Teva Won't Let Regulators, Poison Pill Stop Its Quest for Mylan

Teva has a path to complete the deal.

04/22/15 - 09:46 AM EDT

DuPont, Under Armour Earnings Miss; Crude Oil Loses $56 Level

DuPont, Under Armour Earnings Miss; Crude Oil Loses $56 Level

Benchmark indexes closed mixed Tuesday with the S&P 500 and Dow Jones Industrial Average pressured by a series of poor earnings, while the Nasdaq popped on deals news.

04/21/15 - 04:44 PM EDT

Stick With Mylan Laboratories, Whether Teva Buys It or Not

Stick With Mylan Laboratories, Whether Teva Buys It or Not

Mylan will generate a higher stock price for its shareholders in the coming months, deal or no deal.

04/21/15 - 02:04 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs